Dynavax Technologies Profit Margin

Dynavax Technologies (DVAX) currently reports a profit margin of -13.13% as of September 2025. That compares with 7.89% in the prior-year period — down 266.4% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Dynavax Technologies's profit margin history and peer comparisons.

Dynavax Technologies's profit margin decreased from 7.89% to -13.13% — a 266.4% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Dynavax Technologies's profit margin of -13.13% is lower than the Healthcare sector average of 15.29%. That is roughly 185.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Dynavax Technologies's current -13.13% should be judged against Healthcare norms (sector average: 15.29%) and against DVAX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -13.13%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Dynavax Technologies, and consider following DVAX for alerts when major investors trade the stock.